Dermatology · Charlotte, NC
NPI
1912973801
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
309 S Sharon Amity Rd, Suite 200
Charlotte, NC, 28211
Phone (704) 344-8846
Groups this clinician bills Medicare through
Medicare paid, 2024
$752K
13,085 services
Medicare patients, 2024
1,649
Average age 76
Drug cost, 2024
$3.0M
3,009 prescriptions
Company payments, 2025
$5,590
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher A Snyder was code 17003 (destruction skin lesion), 3,785 times for 564 patients. In total Christopher A Snyder billed 13,085 services in 78 codes, and Medicare paid $752K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,785 | 564 | $4.64 | $18K |
| 99213 Office E&M - Established | Office | 2,212 | 1,303 | $57.15 | $126K |
| 17000 Destruction Skin Lesion | Office | 1,125 | 749 | $35.64 | $40K |
| G6001 Ultrasonic guidance for placement of radiation therapy fields | Office | 764 | 38 | $134.39 | $103K |
| 77280 Radiation Treatment Planning | Office | 755 | 38 | $199.21 | $150K |
| 77401 Conventional Radiation Treatment | Office | 731 | 38 | $30.82 | $23K |
| 17110 Destruction Skin Lesion | Office | 646 | 512 | $75.74 | $49K |
| 11102 Skin Biopsy | Office | 585 | 489 | $58.45 | $34K |
| 96910 Skin | Office | 406 | 15 | $84.72 | $34K |
| 99214 Office E&M - Established | Office | 396 | 316 | $85.98 | $34K |
| 99203 Office E&M - New | Office | 165 | 165 | $66.40 | $11K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 134 | 33 | $0.74 | $99.81 |
| 77336 Radiation Treatment Planning | Office | 114 | 32 | $65.41 | $7,456 |
| 99212 Office E&M - Established | Office | 112 | 98 | $37.62 | $4,213 |
| 17004 Destruction Skin Lesion | Office | 94 | 78 | $114.30 | $11K |
By year: 2022 $450K for 10,028 services; 2023 $776K for 13,133 services; 2024 $752K for 13,085 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher A Snyder prescribed most often to Medicare patients was Triamcinolone Acetonide, with 415 prescriptions and refills. In total Christopher A Snyder wrote 3,009 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 415 | 519 | 280 | $6,942 |
| Ketoconazole Generic | 376 | 408 | 212 | $5,325 |
| Clobetasol Propionate Generic | 244 | 258 | 128 | $9,511 |
| Hydrocortisone Generic | 184 | 195 | 135 | $2,644 |
| Doxycycline Hyclate Generic | 147 | 186 | 57 | $3,244 |
| Betamethasone Dipropionate Generic | 135 | 138 | 71 | $4,773 |
| Hydroxyzine Hcl Generic | 109 | 144 | 29 | $1,413 |
| Cephalexin Generic | 87 | 94 | 51 | $2,184 |
| Prednisone Generic | 84 | 86 | 42 | $311 |
| Minoxidil Generic | 82 | 171 | 31 | $744 |
| Mupirocin Generic | 76 | 76 | 56 | $513 |
| Metronidazole Generic | 66 | 71 | 48 | $3,867 |
| Dupixent Syringe Dupilumab | 62 | 62 | Under 11 | $244K |
| Humira(Cf) Pen Adalimumab | 59 | 61 | Under 11 | $707K |
| Dupixent Pen Dupilumab | 56 | 56 | Under 11 | $214K |
Brand drugs: 459 claims; generic drugs: 2,550 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher A Snyder $5,590 ($5,590 in general payments such as food, travel and fees) from 22 companies. The largest payer was Abbvie Inc. with $617.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $617 |
| LEO Pharma Inc. | 20 | $562 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 22 | $559 |
| Galderma Laboratories, L.P. GALD.SW | 57 | $543 |
| Janssen Biotech, Inc. JNJ | 25 | $457 |
| UCB, Inc. UCB.BR | 19 | $445 |
| Incyte Corporation INCY | 22 | $425 |
| Genzyme Corporation SNY | 17 | $400 |
| Regeneron Healthcare Solutions, Inc. REGN | 13 | $306 |
| Lilly USA, LLC LLY | 21 | $294 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.